AQAI launches TestChest lung-heart function simulator
7 November 2011
The AQAI Simulation Center based in Mainz, Germany, has
launched TestChest, a device that simulates the functioning of the
extremely complex lung and heart-lung functions in humans.
AQAI says it is suitable for use in all contexts where acute and
chronic respiratory conditions are part of education in medicine.
The patient simulator can be programmed for conditions such as
ALI (Acute Lung Injury), ARDS (Acute Respiratory Distress Syndrome),
and COPD (Chronic obstructive pulmonary disease), etc to support
Spontaneous breathing and production of CO2 are part of
TestChest; the simulator reacts in a realistic manner to therapeutic
interventions such as pressure support, PEEP, CPAP, FiO2, and even
recruitment maneuvers. The optional hemodynamics module provides
information on oxygen saturation, heart rate, and intravascular
Features of the AQAI SIS software package include, based on
complex mathematical algorithms, the entire representation of the
patient’s reaction to mechanical ventilation, preconfigured
scenarios, and learning tools, as well as an intuitive user
interface; the package can be combined with existing simulators.
There are no limits to the number of simulated patient cases.
TestChest allows for the realistic re-creation of therapeutic
situations in real time, and makes medical education possible
causing no risks for patients. Modern didactic approaches, such as
problem-based and learner-activated learning, can be realized. The
solution is unique worldwide, and replaces the complicated, hard to
reproduce animal models in use up to the present. The simulator can
also be utilized to test ventilation, CPAP, and anesthetics devices
of all types.